Does Rising Mortgage Rates And Resilient Demand Change The Bull Case For Freddie Mac (FMCC)?

FEDERAL HOME LOAN MORTGAGE CORP

FEDERAL HOME LOAN MORTGAGE CORP

FMCC

0.00

  • In recent weeks, Freddie Mac reported that the average 30-year fixed US mortgage rate rose to 6.52%, while median home sale prices exceeded US$400,000 and pending sales weakened amid elevated housing costs and inflation pressures.
  • Despite higher borrowing costs, Freddie Mac highlighted that existing home sales reached a five-month high as buyers looked past short-term rate moves, suggesting renewed confidence in homeownership.
  • We’ll now examine how rising mortgage rates alongside resilient homebuyer interest could influence Freddie Mac’s existing investment narrative.

Explore 29 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

Federal Home Loan Mortgage Investment Narrative Recap

To be comfortable owning Freddie Mac, you need to believe that its role in providing liquidity to the U.S. housing market can remain valuable even when mortgage rates are elevated and volatile. The latest move to a 6.52% average 30 year fixed rate, alongside still resilient existing home sales, does not materially change the near term catalyst of maintaining solid guarantee and fee income, but it does keep refinance volumes and related revenue under pressure as a key risk.

Among recent developments, Freddie Mac’s rollout of VantageScore 4.0 acceptance stands out in this context, as it may broaden access for qualified borrowers and support origination volumes when affordability is tight. As mortgage rates rise and median prices climb above US$400,000, initiatives that refine credit risk assessment and widen the addressable borrower base tie directly into the company’s ability to sustain guarantee fees and protect earnings quality.

However, against these opportunities, investors should be aware that a prolonged period of higher mortgage rates could...

Federal Home Loan Mortgage's narrative projects $23.7 billion revenue and $0.0 thousand earnings by 2029. This requires 1.2% yearly revenue growth and a $24.0 million earnings increase from -$24.0 million today.

Uncover how Federal Home Loan Mortgage's forecasts yield a $14.70 fair value, a 153% upside to its current price.

Exploring Other Perspectives

FMCC 1-Year Stock Price Chart
FMCC 1-Year Stock Price Chart

Six fair value estimates from the Simply Wall St Community span a wide range from US$11.94 to US$175.13 per share, showing how far apart individual views can be. As you weigh these against Freddie Mac’s sensitivity to sustained high mortgage rates and the potential impact on refinance driven volumes, it is worth exploring several of these alternative perspectives before forming your own view.

Explore 6 other fair value estimates on Federal Home Loan Mortgage - why the stock might be a potential multi-bagger!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

  • A great starting point for your Federal Home Loan Mortgage research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
  • Our free Federal Home Loan Mortgage research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Federal Home Loan Mortgage's overall financial health at a glance.

No Opportunity In Federal Home Loan Mortgage?

Every day counts. These free picks are already gaining attention. See them before the crowd does:

  • Uncover the next big thing with 24 elite penny stocks that balance risk and reward.
  • The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 14 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
  • AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.